ARCHIVES

In Brief: Schmidt Advises Upton To Consider Moving Control Projects In Other Division To DCCR

This article is from The Cancer Letter archive.

Vol. 03 No. 48 | December 2, 1977

Download PDF Visit The Full Archive

Related Articles

ODAC Advice: Avoid ESAs In Curative Settings, Require Patients To Sign Informed Consent.

March 14, 2008

Tamoxifen Listed By IARC Report As Carcinogen CTRF Seeks Applicants

March 1, 1996

FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin

April 5, 1985

No Longer A Hands-Off Shareholder, Roche Seeks Full Control Of Genentech.

July 25, 2008

ORI Finds Misconduct By CIT Professor

August 4, 1995

Studies Test New Agents Offering Relief From Treatment-Related Side Effects

July 30, 2004